Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood–retinal and blood–aqueous barrier breakdown

Edelman, Jeffrey L., Lutz, David, Castro, Marisol R.·2005·Experimental Eye Research
DOI 10.1016/j.exer.2004.09.013

Cited by (246)

Items 201–246 of 246

  1. Comparison of Combined Bevacizumab plus Dexamethasone Vs. Ranibizumab Monotherapy as First-Line Therapy in Patients with Treatment Naive Neovascular Age-Related Macular Degeneration in Real-Life Clinical Practice: A Retrospective Case-Series Analysis
    Nikolaos Vakalis, George Echiadis, Ioannis Deligiannis, S. Giannikakis, Ioannis Papaefthymiou · 2017 · Journal of Clinical & Experimental Ophthalmology
  2. Corticosteroids for the Treatment of Diabetic Macular Edema
    Sumit Kumar Sharma, Prithvi Mruthyunjaya · 2014 · Current Ophthalmology Reports
  3. A Combination of Anatolian Propolis and Curcumin Protects Fibroblasts Against Beclomethasone (Nazal Steroid)-Induced Oxidative Stress by Modulating IL-25, MMP-2, VEGF, and FGF-2 Expressions
    Tarık Yağcı, Sıdıka Genç, Rıza Dündar, Halil İbrahim Altiner, Ali Taghizadehghalehjoughi · 2025 · Pharmaceuticals
  4. Suprachoroidal injection in the treatment of diabetic macular edema: mechanisms, clinical advances, and future perspectives
    Menghan Chen, Wanzhen Jiao, Tianwei Liu, Bojun Zhao · 2026 · Frontiers in Medicine
  5. Barrières hémato-oculaires. Physiologie
    M Patte, I. Sillaire, E. Pauchard, Louise Marie Coulangeon, Bernadette M. Kantelip, F Bacin · 2006 · Encyclopédie médico-chirurgicale. Ophtalmologie
  6. Dexamethasone implant prior to anti-VEGF therapy in pigment epithelium detachments with high-risk rupture characteristics secondary to neovascular age-related macular degeneration
    Barbara Burgos‐Blasco, Noemí Güemes-Villahoz, Samuel Hernández-Ruiz, J. Donate-López, Lorenzo López-Guajardo · 2022 · Archivos de la Sociedad Española de Oftalmología (English Edition)
  7. Prognostic value of choroidal vascular index in determining response to intravitreal dexamethasone implant treatment used in refractory diabetic macular edema
    Serdar İlgüy, Mehmed Uğur Işık · 2023 · Lasers in Medical Science
  8. The Blood-Retinal Barrier
    Sohan Singh Hayreh · 2014 · Springer eBooks
  9. EFEK PEMBERIAN MATRIX METALLOPROTEINASE-9 ( MMP- 9) RNA INTERFERENCE TERHADAP EKSPRESI MMP- 9 PADA KULTUR SEL ENDOTEL VASKULAR
    Lely Retno Wulandari, Hidayat Suyuti, Nadia Artha Dewi, Safaruddin Refa · 2013 · Jurnal Kedokteran Brawijaya
  10. Emerging drugs for diabetic retinopathy
    Antonios Pipis, Stefan Scholl, Albert J. Augustin · 2011 · Expert Opinion on Emerging Drugs
  11. Pathogenesis of Pseudophakic Cystoid Macular Oedema
    Conceição Lopes Lobo · 2012 · European Ophthalmic Review
  12. Extension of peripheral nonperfusion in eyes with retinal vein occlusion during intravitreal dexamethasone treatment
    Sandra Rezar‐Dreindl, Katharina Eibenberger, Wolf Buehl, Günther Weigert, Michael Georgopoulos, Ursula Margarethe Schmidt-Erfurth, Stefan Sacu · 2018 · Acta Ophthalmologica
  13. Treatment Options of Macular Edema Secondary to Retinal Vein Occlusion (RVO): A Review
    Aradhana Pokharel, Jie Luan · 2019 · Open Journal of Ophthalmology
  14. An Acute Retinal Model for Evaluating Blood Retinal Barrier Breach and Potential Drugs for Treatment
    Hao Wu, Ana R. Rodrı́guez, Bernd Werner Spur, Venkat Venkataraman · 2016 · Journal of Visualized Experiments
  15. Ocular effects following aqueocentesis in dogs using variable needle sizes: fluorophotometric and tonometric evaluation
    Rachel A. Allbaugh · 2009 · K-State Research Exchange (Kansas State University)
  16. Endothelial dysfunction in experimental models of preclinical diabetic retinopathy
    John M. Hughes · 2010
  17. Novel Therapeutic Strategies For Posterior Segment Neovascularization
    David P. Bingaman, Xiaolin Gu, Adrian M. Timmers, Alberta A. Davis · 2008 · Springer eBooks
  18. Œdèmes maculaires : les bases de la thérapeutique
    Thomas J. Wolfensberger, Zdenek J Gregor · 2011 · Springer eBooks
  19. Estudio clínico e inmunológico de la acción de adalimumab en el tratamiento de las uveítis inmunomediadas refractarias
    Miguel Cordero Coma · 2014
  20. Efeito da aplicação de acetato de triancinolona sem preservativo (Triensence®) na retina: estudo morfológico, eletrorretinográfico e em cultura de células retinianas
    Leandro Cabral Zacharias · 2013
  21. Tratamento do edema macular difuso do diabético com triancinolona intravítrea e fotocoagulação com laser de argônio
    Fábio Petersen Saraiva · 2008
  22. Medikamentöse Therapie der diabetischen Retinopathie und Makulopathie
    Klaus Dieter Lemmen · 2008 · Der Diabetologe
  23. The Role of Intravitreal Steroids in the Management of Diabetic Retinopathy
    Mark C. Gillies · 2008 · Humana Press eBooks
  24. Efeitos do acetonido de triancinolona associado à panfotocoagulação na retinopatia diabética proliferativa
    Otacílio de Oliveira Maia Júnior · 2008
  25. Intérêt du bevacizumab dans le traitement des occlusions de la veine centrale de la rétine après échec de la triamcinolone
    O. Le Moigne, Alice Duncombe, A. Portmann, M. Muraine, Olivier Genevois · 2012 · Journal Français d Ophtalmologie
  26. A study comparing ranibizumab monotherapy versus ranibizumab plus dexamethasone combination therapy for treatment of diffuse diabetic macular edema
    Ahmed M. Abdel Hadi · 2014 · Journal of the Egyptian Ophthalmological Society
  27. Role of intraocular steroids for the treatment of diabetic macular edema
    Bryan Propes, David Poon, V. Diana · 2009 · Expert Review of Ophthalmology
  28. The Effect of Macular Laser Photocoagulation on Visual Prognosis Before and After Intravitreal Triamcinolone Acetonide Injection in Diabetic Macular Edema
    Sadık Altan Özal, Haluk Esgin · 2015 · Turkiye Klinikleri Journal of Ophthalmology
  29. Exploring the molecular mechanism of ocular angiogenesis inhibition by triamcinolone acetonide
    Wen‐Tao Deng, William W. Hauswirth · 2007 · Expert Review of Ophthalmology
  30. Treatment of Intractable Diabetic Macular Edema with Pegaptanib Versus Bevacizumab, Both in Combination with Dexamethasone
    Diana Leitner, David M. Chacko, Philip Twumasi‐Ankrah, Elizabeth A. Ablah · 2012 · Kansas Journal of Medicine
  31. Nonsurgical Options for the Treatment of Diabetic Macular Edema
    Constantin Jean Pournaras, Efstratios Mendrinos, Jean-Antoine C. Pournaras · 2012 · ESASO course series
  32. Diabetic Retinopathy, Inflammation, and Proteasome
    António Francisco Ambrósio, Paulo Pereira, José Guilherme Cunha-Vaz · 2007 · Springer eBooks
  33. Intravitreal Injections of 4 mg and 20 mg Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema: Comparison of Efficacy and Side Effects
    Erkan Ünsal, Kadir Eltutar, Zeynep Kayaarası Öztürker, Yeliz Acar, Hülya Güngel · 2015 · Turkish Journal of Ophthalmology
  34. Vascular Endothelial Growth Factor in the Aqueous Humor of Dogs With and Without Intraocular Disease
    Christina Sandberg · 2009 · VTechWorks (Virginia Tech)
  35. Diagnosis and management of a patient with idiopathic macular telangiectasia type 2
    Ioannis A. Mallias, Panagiota Mylova, Anastasia Tassiopoulou · 2017 · Ophthalmology Journal
  36. Nonproliferative Diabetic Retinopathy
    Francesco Maria Bandello, Rosangela Lattanzio, Emanuela Aragona, Alessandro Marchese, Giuseppe Querques, Ilaria Zucchiatti · 2018 · Springer eBooks
  37. Upcoming Therapies for Age-related Macular Degeneration
    Meghan Saumur, Christina Y. Weng · 2018 · International Ophthalmology Clinics
  38. Intravitreal injections in veterinary ophthalmology: literature review
    Бояринов Сергей Андреевич, Татьяна Варёнова, Tat'yana Varenova, Шилкин Алексей Германович · 2019 · Russian veterinary journal
  39. Inflammatory Choroidal Vascular Membranes
    Assaf Hilely, Adrian C. Au, David Sarraf · 2020 · Springer eBooks
  40. The treatment of diabetic macular edema: current status and future perspectives.
    André Gomes de Sena · 2012 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  41. Corneal Endothelial Cell Changes Associated with Multiple Intravitreal Injections
    Mariaelena Malvasi, Pietro Mangiantini, Floriana Testa, Edoardo Trovato Battagliola, Mattia D’Andrea, Guglielmo Minozzi, Paolo Turchetti, Elena Pacella · 2024 · Journal of Current Ophthalmology
  42. Regulatory Considerations in Product Development for Back of the Eye
    Ashutosh A. Kulkarni · 2011 · AAPS advances in the pharmaceutical sciences series
  43. Uveitis model in rabbit: Dexamethasone loaded PHBSA nanoparticles
    Ebru Erdal, Barış Batur, Nagihan Uğurlu, Esin Akbay Cetin, Nelisa Türkoğlu Laçin, Cafer Çakal, Murat Demirbilek · 2026 · Experimental Eye Research
  44. Regulation of dystrophin Dp71 during Müller glial cells edema in mouse retina
    Lourdes Siqueiros‐Márquez · 2017
  45. Innovative low-cost suprachoroidal triamcinolone acetate delivery system
    Pramod Kumar Sharma, Santosh Kumar Mahapatra, Ruturaj Sahoo, Anjalika Parhi, Rohit Amol Chavan, Ayantika Das, Amit Bidasaria · 2026 · Taiwan Journal of Ophthalmology
  46. Optimizing the co-assembly of hydrophobic amino acid-modified hexahistidine and bevacizumab for near-complete inhibition of corneal neovascularization
    Wenlian Ye, 蒋田芳, 金岳嵠, 金岳嵠, 蔡谨, 蔡谨, Xingjie Zan, Lisha Ye · 2026 · Acta Biomaterialia